Dr Tang and Dr Wong implanted the first VasQ device [Laminate Medical Technologies] in private practice in Singapore on the 30 October 2023. This device which has been commercially available in the US and Europe is used to aid arteriovenous fistula (AVF) maturation and minimise reinterventions. This is an external support device and is implanted at the time of AVF creation and is placed over the anastomosis or near the join between the artery and the outflow vein.
Thousands have been clinically implanted in Europe and VasQ AVF usability ranges from 87-100% compared to 40-72% standard AVF usability. This device will likely help our AVF maturation rates in Singapore as our Asian patient veins and arteries are generally 10-20% smaller than our Caucasian counterparts. The current state of vascular access in Singapore reported only 55-78% conventional AVFs were functional at 3 months.
目前数据显示：
- Use of VasQ demonstrates excellent AVF maturation and patency rates with low frequency of assisted maturation and interventions for maintenance
- Higher functional success rates for VasQ AVFs compared to standard AVFs
- 美国成本分析表明，前 6 个月内干预的减少导致每位患者每年的成本减少约 11,000 美元！
Happy to report that the AVF created is thrilling beautifully at one week and patient is delighted with her progress!
The external support device VasQ used for a left brachiocephalic fistula creation
唐医生、黄医生和麻醉师 Kevin Chan 在手术过程中。病例在神经阻滞下成功完成，患者清醒且非常舒适。
